Table 1.
Baseline characteristics of the study cohort.
| Characteristic | Study population (n=46) |
|---|---|
| Age (years) | 57±11 |
| Female | 6 (13) |
| Body mass index (kg/m2) | 27±3 |
| Hypertension | 36 (78) |
| Blood pressure (mmHg) | 131±26/77±12 |
| Family history for AMI | 12 (26) |
| Smoking status | 19 (41) |
| Hyperlipidaemia | 32 (70) |
| Total cholesterol (mg/dl) | 182±44 |
| Diabetes mellitus | 5 (11) |
| CKD | 3 (6) |
| Creatinine | 0.91±0.17 |
| eGFR (ml/min/1.73m2) | 91±19 |
| Anterior STEMI | 20 (43) |
| Number of diseased vessels | |
| 1 | 24 (52) |
| 2 | 18 (39) |
| 3 | 4 (9) |
| Left ventricular ejection fraction (%) | 54±11 |
| CK max (U/l) | 2206 (1156–4058) |
| cTnT max (ng/l) | 6161 (3739–9237) |
| NT-proBNP max(ng/l) | 1155 (616–2214) |
| hs-CRP max (mg/dl) | 2.4 (1.1–5.0) |
| Adiponectin (ng/ml) | 2385 (1735–5403) |
Values are given as mean±standard deviation, n (%), or median (interquartile range).
AMI, acute myocardial infarction; CK, creatine kinase; CKD, chronic kidney disease; cTnT, cardiac troponin T; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; STEMI, ST-segment elevation myocardial infarction.